BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22761859)

  • 1. Informed consent and placebo effects: a content analysis of information leaflets to identify what clinical trial participants are told about placebos.
    Bishop FL; Adams AE; Kaptchuk TJ; Lewith GT
    PLoS One; 2012; 7(6):e39661. PubMed ID: 22761859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
    Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
    Trials; 2024 May; 25(1):339. PubMed ID: 38778336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
    Cheon S; Park HJ; Chae Y; Lee H
    BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing Adults With Back Pain About Placebo Effects: Randomized Controlled Evaluation of a New Website With Potential to Improve Informed Consent in Clinical Research.
    Bishop FL; Greville-Harris M; Bostock J; Din A; Graham CA; Lewith G; Liossi C; O'Riordan T; White P; Yardley L
    J Med Internet Res; 2019 Jan; 21(1):e9955. PubMed ID: 30664462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial participants' self-reported understanding of randomisation phrases in participation information leaflets can be high, but acceptability of some descriptions is low, especially those linked to gambling and luck.
    Shiely F; Murphy E; Gilles K; Hood K; O'Sullivan L; Harman N; Isaacs T; Treweek S
    Trials; 2024 Jun; 25(1):391. PubMed ID: 38890748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
    Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
    Trials; 2014 Feb; 15():62. PubMed ID: 24548781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
    Cuddihy L; Howick J; Murphy E; Shiely F
    Trials; 2024 May; 25(1):292. PubMed ID: 38693579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What trial participants need to be told about placebo effects to give informed consent: a survey to establish existing knowledge among patients with back pain.
    Hughes J; Greville-Harris M; Graham CA; Lewith G; White P; Bishop FL
    J Med Ethics; 2017 Dec; 43(12):867-870. PubMed ID: 28663259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.
    Kirby N; Shepherd V; Howick J; Betteridge S; Hood K
    Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information about dissemination of trial results in patient information leaflets for clinicals trials in the UK and Ireland: The what and the when.
    Bjorklund M; Shiely F; Gillies K
    PLoS One; 2022; 17(5):e0268898. PubMed ID: 35609047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
    Murphy E; Gillies K; Shiely F
    Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scientific tools, fake treatments, or triggers for psychological healing: how clinical trial participants conceptualise placebos.
    Bishop FL; Jacobson EE; Shaw JR; Kaptchuk TJ
    Soc Sci Med; 2012 Mar; 74(5):767-74. PubMed ID: 22285289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach.
    Innes K; Cotton S; Campbell MK; Elliott J; Gillies K
    BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug trials are more likely to disclose full placebo control information than non-drug trials: A cross-sectional study of participant information leaflets of placebo-controlled trials.
    Won J; Han JY; Ji YJ; Ha D; Han BJ; Lee H
    Integr Med Res; 2024 Jun; 13(2):101043. PubMed ID: 38779540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "I assumed that one was a placebo": exploring the consent process in a sham controlled acupressure trial.
    Hughes JG; Russell W; Breckons M; Richardson J; Lloyd-Williams M; Molassiotis A
    Complement Ther Med; 2014 Oct; 22(5):903-8. PubMed ID: 25440382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The definition of placebo in the informed consent forms of clinical trials.
    Hernández A; Baños JE; Llop C; Farré M
    PLoS One; 2014; 9(11):e113654. PubMed ID: 25423149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.